Experiencing neonatal maternal separation increased pain sensitivity in adult male mice: Involvement of oxytocinergic system
Autor: | Shahram Ejtemaie Mehr, Sakineh Alijanpour, Hossein Amini-Khoei, Simin Poursaman, Ehsanollah Sadeghi, Azam Mesdaghinia, Ahmad Reza Dehpour, Hamid Reza Banafshe, Elika Samiei, Shayan Amiri, Mojgan Rastegar, Arya Haj-Mirzaian, Ali Mohammadi-Asl |
---|---|
Rok vydání: | 2017 |
Předmět: |
Male
Pain Threshold 0301 basic medicine medicine.medical_specialty medicine.drug_class Pain Oxytocin Naltrexone Mice 03 medical and health sciences Cellular and Molecular Neuroscience Hormone Antagonists Vasotocin 0302 clinical medicine Endocrinology Internal medicine Threshold of pain medicine Animals Endogenous opioid Opioidergic Endocrine and Autonomic Systems Maternal Deprivation Antagonist General Medicine Analgesics Opioid 030104 developmental biology Nociception Neurology Opioid Female Psychology Stress Psychological 030217 neurology & neurosurgery Opioid antagonist medicine.drug |
Zdroj: | Neuropeptides. 61:77-85 |
ISSN: | 0143-4179 |
DOI: | 10.1016/j.npep.2016.11.005 |
Popis: | Early-life stress adversely affects the development of the brain, and alters a variety of behaviors such as pain in later life. In present study, we investigated how early-life stress (maternal separation or MS) can affect the nociceptive response later in life. We particularly focused on the role of oxytocin (OT) in regulating nociception in previously exposed (MS during early postnatal development) mice that were subjected to acute stress (restraint stress or RS). Further, we evaluated whether such modulation of pain sensation in MS mice are regulated by shared mechanisms of the OTergic and opioidergic systems. To do this, we assessed the underlying systems mediating the nociceptive response by administrating different antagonists (for both opioid and OTergic systems) under the different experimental conditions (control vs MS, and control plus RS vs MS plus RS). Our results showed that MS increased pain sensitivity in both tail-flick and hot-plate tests while after administration of OT (1μg/μl/mouse, i.c.v) pain threshold was increased. Atosiban, an OT antagonist (10μg/μl/mouse, i.c.v) abolished the effects of OT. While acute RS increased the pain threshold in control (and not MS) mice, treating MS mice with OT normalized the pain response to RS. This latter effect was reversed by atosiban and/or naltrexone, an opioid antagonist (0.5μg/μl/mouse, i.c.v) suggesting that OT enhances the effect of endogenous opioids. OTergic system is involved in mediating the nociception under acute stress in mice subjected to early-life stress and OTergic and opioidergic systems interact to modulate pain sensitivity in MS mice. |
Databáze: | OpenAIRE |
Externí odkaz: |